More news
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (24)
- Nov (34)
- Dec (20)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
A very rigorous management of peripheral infections may be beneficial in Multiple Sclerosis
Infections trigger the immune system, responsible for fighting them. On the other hand, there is evidence that the innate immune system is involved1
GATA 6 mutations cause pancreatic agenesis in humans
Pancreatic agenesis carries neonatal diabetes requiring insulin treatment and exocrine pancreatic insufficiency requiring enzyme replacement therapy1
The HCB-IDIBAPS Biobank launches a new area devoted to ancient DNA
In September the Biobank of the Hospital Clínic - IDIBAPS expanded its platform with the opening of a fourth area, the Bank of ancient DNA. The ancie1
Tres especialistes del Clínic reben el premi 2011 del COMB a l'Excel·lència Professional
Post-exposure prophylaxis may reduce the risk of transmission after exposure to HIV
Emergence of new HIV carriers does not stop despite the great efforts focused in its prevention. Between 2001 and 2010 the rate of new infections rem1
Homenatge sorpresa dels companys al Dr. Josep M. Bordas
El passat dilluns 28 de novembre els membres de la Unitat d'Endoscòpia tenien una cita especial a la sala d'actes Farreras Valentí per homenatjar al1
Belimumab is the first treatment specifically developed for SLE in over 50 years
GlaxoSmithKline (GSK) and Human Genome Sciences (HGS) presented BENLYSTA (belimumab). This is a treatment for adult patients with systemic lupus eryt1